Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.08.03.551759v1?rss=1
Authors: Choudhery, S., DeJesus, M., Srinivasan, A., Rock, J., Schnappinger, D., Ioerger, T.
Abstract: An important application of CRISPR interference (CRISPRi) technology is for identifying chemical-genetic interactions (CGIs). Discovery of genes that interact with exposure to antibiotics can yield insights to drug targets and mechanisms of action or resistance. The premise is to look for CRISPRi mutants whose relative abundance is suppressed (or enriched) in the presence of a drug when the target protein is depleted, reflecting synergistic behavior. One thing that is unique about CRISPRi experiments is that sgRNAs for a given target can induce a wide range of protein depletion. The effect of sgRNA strength can be partially predicted based on sequence features or empirically quantified by a passaging experiment. sgRNA strength interacts in a non-linear way with drug sensitivity, producing an effect where the concentration-dependence is maximized for sgRNAs of intermediate strength (and less so for sgRNAs that induce too much or too little target depletion). sgRNA strength has not been explicitly accounted for in previous analytical methods for CRISPRi. We propose a novel method for statistical analysis of CRISPRi CGI data called CRISPRi-DR (for Dose-Response model). CRISPRi-DR incorporates data points from measurements of abundance at multiple inhibitor concentrations using a classic dose-response equation. Importantly, the effect of sgRNA strength can be incorporated into this model in a way that mimics the non-linear interaction between the two covariates on mutant abundance. We use CRISPRi-DR to re-analyze data from a recent CGI experiment in Mycobacterium tuberculosis and show that genes known to interact with various anti-tubercular drugs are ranked highly. We observe similar results in MAGeCK, a related analytical method, for datasets of low variance. However, for noisier datasets, MAGeCK is more susceptible to false positives whereas CRISPRi-DR maintains higher precision, which we observed in both empirical and simulated data, due to CRISPRi-DRs integration of data over multiple concentrations and sgRNA strengths.
Copy rights belong to original authors. Visit the link for more info
Podcast created by Paper Player, LLC